Thomas Tobin, MVB, MSc, Ph.D, MRCVS, DABT

Professional Profile

Employment

Professor of Veterinary Science, Gluck Equine Research Center, U.K.

Professor, Graduate Center for Toxicology, U.K.

Intellectual Property

Patent for a morphine/drug detection technique, 1983. WTT, Inc., created with licenses for 50-plus ELISA tests, 1991. Sold to Neogen, Inc. as ELISA Technologies, 1993. Currently, 100 employees  in Lexington, $30M sales, significant UK royalty. Thirty-plus unique equine drug metabolites and deuterated standards synthesized and licensed. Patent for treatment of EPM granted, licensed and marketed as Marquis®, August 2001, significant UK royalty. Other patents/ intellectual properties in progress. Unique mathematical analysis and biologically unique proposed pathogenesis of MRLS copyrighted (TXVIIII484). Publishing/other royalties.

Publications

About 400-papers, 100-plus abstracts, two books, five volumes of proceedings. Numerous articles published and reprinted in lay journals. See www.thomastobin.com for a full indexed listing of publications and presentations.

Drugs and the Performance Horse, by Thomas Tobin. Foreword by HRH, The Duke of Edinburgh. 480 pp., Springfield, Illinois: Charles C. Thomas, 1981.

Proceedings of the Workshop on Testing for Therapeutic Medications, Environmental and Dietary Substances in Racing  Horse. 218 pages, 1995.

Proceedings of the First Workshop on Mare Reproductive Loss Syndrome. 134 pages, 2002.

Curriculum Vitae

http://www2.ca.uky.edu/gluck/TobinT_CV.asp

Education

MVB (DVM); University College, Dublin, 1964

MSc; Pharmacology, University of Guelph, 1966

PhD; Pharmacology-Toxicology, University of Toronto,1970

Areas of Interest